Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Actitan F
- Development stage
- Phase 4
- Lead developer
- Aboca
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Actitan F is a natural molecular complex formulated primarily for the management of acute and chronic diarrhea in children. It consists of tannins derived from Agrimonia (agrimony) and Tormentilla (tormentil), as well as flavonoids from Chamomile. The product acts by exerting a protective effect on the intestinal mucosa, counteracting inflammation associated with diarrhea, and normalizing stool consistency without causing constipation. Its mechanism involves binding to inflammatory proteins such as IL-6 and viral proteins like Rotavirus NSP4, thereby reducing their activity in the gut. Clinical studies have shown that Actitan F is safe and effective in shortening the duration of acute gastroenteritis in pediatric populations[2][5][7]. It is typically administered orally as part of supportive therapy for diarrhea.
- Brand names
- Actitan FLenodiar Pediatric
- Other names
- Actitan-F
02
Targets
NSP4 (Rotavirus non-structural glycoprotein 4)
Beyond the preview
Go deeper on Actitan F.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Actitan F.